Citius Pharmaceuticals, Inc. (CTXR)
0.585
-0.02
(-2.82%)
USD |
NASDAQ |
Sep 04, 15:11
Citius Pharmaceuticals Enterprise Value : 15.99M for Sept. 3, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 15.99M |
| September 02, 2026 | 15.37M |
| September 01, 2026 | 15.09M |
| August 31, 2026 | 15.39M |
| August 28, 2026 | 15.99M |
| August 27, 2026 | 16.73M |
| August 26, 2026 | 15.31M |
| August 25, 2026 | 16.04M |
| August 24, 2026 | 15.26M |
| August 21, 2026 | 15.94M |
| August 20, 2026 | 15.93M |
| August 19, 2026 | 16.97M |
| August 18, 2026 | 15.16M |
| August 17, 2026 | 14.89M |
| August 14, 2026 | 20.21M |
| August 13, 2026 | 19.60M |
| August 12, 2026 | 20.47M |
| August 11, 2026 | 19.23M |
| August 10, 2026 | 18.05M |
| August 07, 2026 | 18.20M |
| August 06, 2026 | 17.09M |
| August 05, 2026 | 20.90M |
| August 04, 2026 | 16.55M |
| August 03, 2026 | 15.83M |
| July 31, 2026 | 15.11M |
| Date | Value |
|---|---|
| July 30, 2026 | 16.81M |
| July 29, 2026 | 15.09M |
| July 28, 2026 | 13.14M |
| July 27, 2026 | 13.65M |
| July 24, 2026 | 13.75M |
| July 23, 2026 | 14.05M |
| July 22, 2026 | 14.90M |
| July 21, 2026 | 14.44M |
| July 20, 2026 | 12.66M |
| July 17, 2026 | 13.08M |
| July 16, 2026 | 13.48M |
| July 15, 2026 | 14.04M |
| July 14, 2026 | 14.07M |
| July 13, 2026 | 14.29M |
| July 10, 2026 | 15.46M |
| July 09, 2026 | 14.87M |
| July 08, 2026 | 14.76M |
| July 07, 2026 | 15.48M |
| July 06, 2026 | 16.14M |
| July 02, 2026 | 15.24M |
| July 01, 2026 | 16.18M |
| June 30, 2026 | 16.06M |
| June 29, 2026 | 16.71M |
| June 26, 2026 | 15.84M |
| June 25, 2026 | 15.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Citius Oncology, Inc. | 77.43M |
| ANI Pharmaceuticals, Inc. | 1.888B |
| Corcept Therapeutics, Inc. | 11.87B |
| Veru, Inc. | 22.07M |
| Johnson & Johnson | 698.80B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.92M |
| Revenue (Quarterly) | 1.494M |
| Total Expenses (Quarterly) | 10.36M |
| EPS Diluted (Quarterly) | -0.3387 |
| Gross Profit Margin (Quarterly) | -48.09% |
| Profit Margin (Quarterly) | -797.9% |
| Earnings Yield | -360.8% |
| Normalized Earnings Yield | -360.77 |